NuWays keeps OHB at Buy, sets EUR 340 price target

• NuWays reiterated a BUY rating on OHB, setting a 12-month target price of EUR 340 on a DCF basis.
• The firm highlighted Q2 margin expansion, pointing to adjusted EBITDA up 27% to EUR 33 million, with the margin rising 1.4pp to 9.5%.
• It flagged EUR 22.4 million in one-off costs, mainly tied to capital increase transaction expenses, as a drag on reported EBITDA and earnings estimates.
• NuWays said order intake should trough in Q2, citing EUR 299 million of intake and an expected pickup in H2 as major awards approach.
• It identified IRIS² as the key near-term contract catalyst, with signing expected in H2, supported by a net cash balance sheet position.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OHB SE published the original content used to generate this news brief via EQS News (Ref. ID: rc_26438) on August 07, 2026, and is solely responsible for the information contained therein.